HOSPITAL UNIVERSITARIO VITHAS MADRID
Departamento
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (41)
2024
-
Baroreflex activation therapy in patients with heart failure and reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 342-344
-
Cardiovascular surgery and cardiology, current status of two sister specialties in Spain: the CARDIOXCARDIO study
Revista Espanola de Cardiologia
-
Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure
ESC Heart Failure, Vol. 11, Núm. 3, pp. 1767-1776
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort
International Journal of Cardiology, Vol. 405
-
Repetitive ambulatory levosimendan as a bridge to heart transplantation
Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301
-
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
European Journal of Internal Medicine
2023
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry
Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Clinical Research in Cardiology
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry
Journal of the American Heart Association, Vol. 11, Núm. 13
-
Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing
PLoS ONE, Vol. 17, Núm. 2 February
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
Journal of Clinical Medicine, Vol. 11, Núm. 20
-
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278